| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | AWT-IR_1 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-IR_2 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-IR_3 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-IRMIF20_1 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-IRMIF20_2 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-IRMIF20_3 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-Sham_1 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-Sham_2 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-Sham_3 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-ShamMIF20_1 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-ShamMIF20_2 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | AWT-ShamMIF20_3 | Sample source:Heart | Age:Aged | Genotype:WT | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-IR_1 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-IR_2 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-IR_3 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-IRMIF20_1 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-IRMIF20_2 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-IRMIF20_3 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-Sham_1 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-Sham_2 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-Sham_3 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-ShamMIF20_1 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-ShamMIF20_2 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | cMIFKO-ShamMIF20_3 | Sample source:Heart | Age:NA | Genotype:KO-MIF | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-IR_1 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-IR_2 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-IR_3 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-IRMIF20_1 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-IRMIF20_2 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-IRMIF20_3 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-Sham_1 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-Sham_2 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-Sham_3 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-ShamMIF20_1 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-ShamMIF20_2 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | MIFff-ShamMIF20_3 | Sample source:Heart | Age:NA | Genotype:MIF | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-IR_1 | Sample source:Heart | Age:young | Genotype:WT | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-IR_2 | Sample source:Heart | Age:young | Genotype:WT | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-IR_3 | Sample source:Heart | Age:young | Genotype:WT | Treatment:I/R | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-IRMIF20_1 | Sample source:Heart | Age:young | Genotype:WT | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-IRMIF20_2 | Sample source:Heart | Age:young | Genotype:WT | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-IRMIF20_3 | Sample source:Heart | Age:young | Genotype:WT | Treatment:I/R+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-Sham_1 | Sample source:Heart | Age:young | Genotype:WT | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-Sham_2 | Sample source:Heart | Age:young | Genotype:WT | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-Sham_3 | Sample source:Heart | Age:young | Genotype:WT | Treatment:Sham | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-ShamMIF20_1 | Sample source:Heart | Age:young | Genotype:WT | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-ShamMIF20_2 | Sample source:Heart | Age:young | Genotype:WT | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
| Reversed phase UNSPECIFIED ION MODE | YWT-ShamMIF20_3 | Sample source:Heart | Age:young | Genotype:WT | Treatment:Sham+MIF20 | lipid content in the sample (nmol/g) |
Return to study ST003222 main page
Download data matrix(A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 Reversed phase UNSPECIFIED ION MODE)
- Metabolomics Workbench
|